Cargando…

Anxiety Symptoms in Patients with Major Depressive Disorder: Commentary on Prevalence and Clinical Implications

The prevalence of major depressive disorder (MDD) has been increasing, and MDD is now a leading cause of global disability. Depression often coexists with anxiety, and the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) introduced the ‘anxious distress’ specifier to...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hopwood, Malcolm
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141876/ https://www.ncbi.nlm.nih.gov/pubmed/37115459 http://dx.doi.org/10.1007/s40120-023-00469-6

Ejemplares similares

Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2023)

Commentary on Cochrane review: “Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder”
por: Borentain, Stephane, et al.
Publicado: (2022)

Common and Distinct Gray Matter Alterations in Social Anxiety Disorder and Major Depressive Disorder
por: Frick, Andreas
Publicado: (2017)

Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder
por: Thase, Michael E., et al.
Publicado: (2014)

EBNEO commentary: Elevated depression and anxiety symptoms in parents of very preterm infants while hospitalised and post‐discharge
por: Swenson, Sarah A., et al.
Publicado: (2022)

Association between socioeconomic inequality and the global prevalence of anxiety and depressive disorders: an ecological study
por: Shahbazi, Fatemeh, et al.
Publicado: (2022)

Are Worry and Rumination Specific Pathways Linking Neuroticism and Symptoms of Anxiety and Depression in Patients with Generalized Anxiety Disorder, Major Depressive Disorder and Mixed Anxiety-Depressive Disorder?
por: Merino, Hipólito, et al.
Publicado: (2016)

The Relationship Between Depression Symptoms and Anxiety Symptoms During Acute ECT for Patients With Major Depressive Disorder
por: Huang, Chun-Jen, et al.
Publicado: (2019)

Mapping the Presence of Anxiety Symptoms in Adults With Major Depressive Disorder
por: Ge, Fenfen, et al.
Publicado: (2021)

Commentary: Preventative indications for major resection
por: Olive, Jacqueline K., et al.
Publicado: (2020)

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study
por: Davis, Lori L., et al.
Publicado: (2016)

Genetic and Environmental Contribution to Major Depressive Disorder and Self-declared Depression
por: Fabbri, Chiara
Publicado: (2016)

Prevalence of Comorbid Anxiety Disorders and Their Associated Factors in Patients with Bipolar Disorder or Major Depressive Disorder
por: Inoue, Takeshi, et al.
Publicado: (2020)

Commentary to the Article Entitled “Cancer Pain, Anxiety and Depression in Admitted Patients in a Tertiary Care Hospital – A Prospective Observational Study”
por: Ghoshal, Arunangshu
Publicado: (2020)

Finding the Stripes: Distinguishing Bipolar Disorder From Major Depressive Disorder
por: MacMaster, Frank P.
Publicado: (2017)

The impacts of migraine and anxiety disorders on painful physical symptoms among patients with major depressive disorder
por: Hung, Ching-I, et al.
Publicado: (2014)

Major depressive disorder and the gut microbiome: what is the link?
por: Modesto Lowe, Vania, et al.
Publicado: (2023)

Adapting the Goal Attainment Approach for Major Depressive Disorder
por: McCue, Maggie, et al.
Publicado: (2019)

Symptoms of Depression, Anxiety, and Stress and Prevalence of Major Depression and Its Predictors in Female University Students
por: Blanco, Vanessa, et al.
Publicado: (2021)

Role of Spirituality in the Management of Major Depression and Stress-Related Disorders
por: Varghese, Sajoy P., et al.
Publicado: (2021)

The role of leptin in indirectly mediating “somatic anxiety” symptoms in major depressive disorder
por: Zhu, Yue, et al.
Publicado: (2022)

Commentary on: Burnout in the Plastic Surgeon: Implications and Interventions
por: Noone, R. Barrett
Publicado: (2017)

What Do Patients Want in the Treatment of Major Depressive Disorder? Taiwan’s TAILOR Survey
por: Chang, Chia-Ming
Publicado: (2023)

Commentary on a recent review of lithium toxicity: what are its implications for clinical practice?
por: Müller-Oerlinghausen, Bruno, et al.
Publicado: (2012)

Commentary: Hyperreflective foci on optical coherence tomography and their clinical implications in diabetic macular edema
por: Deb, Amit K, et al.
Publicado: (2021)

The patient perspective in research on major depression
por: Cuijpers, Pim
Publicado: (2011)

Evaluation of major depression in a routine clinical assessment
por: Mezzasalma, Marco André Urbach
Publicado: (2010)

Is placebo useful in the treatment of major depression in clinical practice?
por: Marchesi, Carlo, et al.
Publicado: (2013)

Risk Factors for Anxiety in Major Depressive Disorder Patients
por: Xin, Li-Min, et al.
Publicado: (2015)

Mosquitoes are not the major culprits for the high burden of malaria in Nigeria: a commentary
por: Aju-Ameh, Celina Onyawoibi
Publicado: (2020)

Prevalence of anxiety and depressive symptoms among patients with hypothyroidism
por: Bathla, Manish, et al.
Publicado: (2016)

The Hospital Anxiety And Depression Scale
por: Snaith, R Philip
Publicado: (2003)

Commentary – Autism Spectrum Disorder: Spectrum or Cluster?
por: Pruett, John R., et al.
Publicado: (2016)

Commentary: The utility of automated pupillometry in retinal disorders
por: Shenoy, Pratik, et al.
Publicado: (2021)

Unexplained Painful Physical Symptoms in Patients with Major Depressive Disorder: Prevalence, Pathophysiology and Management
por: Jaracz, Jan, et al.
Publicado: (2016)

Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity
por: Lyndon, Gavin J., et al.
Publicado: (2019)

Prospective mental imagery in patients with major depressive disorder or anxiety disorders
por: Morina, Nexhmedin, et al.
Publicado: (2011)

How prevalent are depression and anxiety symptoms in hypothyroidism?
por: Praharaj, Samir Kumar
Publicado: (2016)

Shared genetic correlation and causal association between major depressive disorder and breast cancer
por: Ohi, Kazutaka
Publicado: (2023)

Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer
por: dos Santos, Rafael Guimarães, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rk519dsjj1fr1ssnelatpmosue